Type:

Promising results as Viaskin Peanut trial in peanut-allergic toddlers concludes 14th June 2022

A recent trial by DBV Technologies has produced promising results for very young children with peanut allergies and their families. The trial assessed whether Viaskin Peanut – an immunotherapy skin patch – was safe, and if it worked for children

Read more
Study highlights importance of new peanut allergy treatments 31st May 2022

New research investigating the emotional impact of living with a peanut allergy has empathised the importance of exploring potential treatments. The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation

Read more
Trends in the use of specialised formula for cow’s milk allergy in young children 29th May 2022

A study exploring trends in the use of specialised formula for cow’s milk allergy in young children has found a 2.8 fold increase since 2008 exceeding expected levels.

Read more
Study recommendations could reduce milk allergy overdiagnosis 26th May 2022

These recommendations aim to safely reduce overdiagnosis and better support breastfeeding women whose children have suspected a milk allergy. 

Read more
Study highlights importance of new peanut allergy treatments 20th May 2022

New research investigating the emotional impact of living with a peanut allergy has empathised the importance of exploring potential treatments. The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of

Read more
New clinical trial from the Natasha Allergy Research Foundation 18th May 2022

Congratulations to the Natasha Allergy Research Foundation, which is running a new clinical trial in oral immunotherapy, focusing on children with milk and peanut allergies. The research will investigate whether these allergies can be effectively treated with everyday foods instead

Read more
Exploring health-related quality of life burden in peanut allergy and the potential benefit of oral immunotherapy: estimation of health state utility values for patients and caregivers   7th May 2022

The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers highlighted the detrimental impact living with a peanut allergy can have on both the person with the allergy and their parent or caregiver.

Read more
Burden of allergic disease among ethnic minority groups in high income countries 20th March 2022

The review explored why ethnic minority patients with allergic disease have poorer clinical outcomes than the indigenous population.

Read more
Understanding the risk factors for peanut allergy  2nd February 2022

A study exploring early-life predictors and risk factors of peanut allergy, and its association with asthma in later-life has found that peanut allergy is associated with multiple IgE sensitization and early-onset persistent eczema and wheeze.

Read more